An experimental gene therapy slowed Huntington’s by up to 75 percent in a small clinical trial. While not a cure, it may give patients longer lives.

Jagadeesha's brain, the first juvenile Huntington's Disease donation in India, offers hope for vital neurodegenerative research at NIMHANS.

Eight years later, suffering from frequent falls, involuntary movements, and the inability to eat, Sarah’s grandmother passed ...

UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy for Huntington's disease may be adequate for a marketing application, ...

Huntington’s disease (HD) is a progressive, inherited neurological disorder that affects movement, cognition, and behavior. Managing the condition effectively requires a combination of medical ...

People with Huntington’s disease often lose control over their voluntary movements, which can affect daily functioning more severely than the involuntary jerks caused by chorea. Difficulties with ...

Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...

BOCA RATON, Fla. — An estimated 41,000 Americans are affected by a neuro-degenerative disorder called Huntington‘s disease, and more than 200,000 are at risk of inheriting the disease according to the ...

What is Huntington's Disease? Huntington's disease (HD) is a hereditary and deadly disorder that causes nerve cells in the brain to break down. This causes physical and mental abilities to weaken, and ...

Researchers from the University of Oxford have identified a key biochemical mechanism relevant to the development of Huntington's Disease. This discovery opens up the possibility of studying the ...

Scientists are unraveling the mystery of what triggers Huntington’s disease, a devastating and fatal hereditary disorder that strikes in the prime of life, causing nerve cells in parts of the brain to ...